Tectonic Therapeutics TECX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$25.24M-31.3% | -$19.23M-1.0% | -$19.04M+4.7% | -$19.98M-25.6% | -$15.91M-28.6% | ||
| $304K-8.7% | $333K-2.6% | $342K+0.6% | $340K-5.6% | $360K-29.1% | ||
| $3.21M+7.2% | $2.99M+6.1% | $2.82M+8.8% | $2.59M+23.1% | $2.1M+88.3% | ||
| -$23K— | $0+100% | -$93K-55.0% | -$60K— | $0— | ||
| $1.38M— | —— | —— | $137K-91.4% | $1.58M+210% | ||
| $1.63M— | —— | —— | —— | -$3.42M-7.1% | ||
| $23K+264% | -$14K— | —— | —— | -$14K+98.0% | ||
| $496K-9.5% | $548K+2.4% | $535K+2.1% | $524K+2.5% | $511K— | ||
| -$147K+75.2% | -$593K-2.1% | -$581K-2.3% | -$568K-2.7% | -$553K— | ||
| -$18.41M-27.3% | -$14.46M+18.8% | -$17.82M-21.0% | -$14.72M-12.5% | -$13.08M+22.2% | ||
| $19K— | —— | $181K— | —— | $27K+800% | ||
| —— | —— | $15K— | —— | —— | ||
| -$19K— | $0+100% | -$166K-402% | $55K+304% | -$27K-800% | ||
| $100K+69.5% | $59K+883% | $6K-96.9% | $194K-80.0% | $972K+8.1% | ||
| $105K-17.3% | $127K+3.3% | $123K+1.7% | $121K+2.5% | $118K+2.6% | ||
| $412K— | —— | —— | $17K— | $0— | ||
| $847K— | —— | —— | —— | $178.12M— | ||
| $94K+369% | -$35K-52.2% | -$23K+28.1% | -$32K-540% | -$5K— | ||
| -$17.49M— | —— | —— | —— | $165.01M— | ||
| —— | —— | —— | —— | —— | ||
| $1.63M— | —— | —— | —— | -$3.42M-7.1% | ||
| -$147K+75.2% | -$593K-2.1% | -$581K-2.3% | -$568K-2.7% | -$553K— | ||
| $46K+104% | -$1.25M— | —— | —— | -$2.22M-205% | ||
| $496K-9.5% | $548K+2.4% | $535K+2.1% | $524K+2.5% | $511K— | ||
| $105K-17.3% | $127K+3.3% | $123K+1.7% | $121K+2.5% | $118K+2.6% | ||
| $1.26M— | —— | —— | —— | $0— | ||
| $0— | —— | —— | —— | $177.27M— | ||
| -$147K+75.2% | -$593K-2.1% | -$581K-2.3% | -$568K-2.7% | -$553K— | ||
| $3.73M— | —— | —— | —— | $0— | ||
| —— | $8.75K0.0% | $8.75K0.0% | $8.75K0.0% | $8.75K— | ||
| $0— | —— | —— | —— | $4.17M— | ||
| $79K— | —— | —— | $107K— | $0— | ||
| $21K— | —— | —— | —— | $0— | ||
| -$18.43M-27.5% | -$14.46M+19.6% | -$18M-22.3% | -$14.72M-12.3% | -$13.11M+22.1% | ||
| -$18.43M-27.5% | -$14.46M+19.6% | -$18M-22.3% | -$14.72M-12.3% | -$13.11M+22.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tectonic Therapeutics generate?
- Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
- What is Tectonic Therapeutics's free cash flow?
- After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
- Where does Tectonic Therapeutics's cash flow data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.